BioSpace News Archive

Pharm Country

Teleflex to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top conference at the Goldman Sachs Office in New York, NY, on Thursday, January 9, 2020 at 2:50 p.m. (ET).

December 30, 2019
·
1 min read
BioCapital

LYNPARZA (Olaparib) Approved in the US as a 1st-line Maintenance Treatment of Germline BRCA-mutated Metastatic Pancreatic Cancer

LYNPARZA reduced the risk of disease progression or death by 47% in patients whose disease had not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen

December 30, 2019
·
17 min read
Business

Avanos Medical Appoints Michael C. Greiner as Chief Financial Officer

Greiner brings to Avanos more than 20 years of experience in corporate finance, accounting, treasury and M&A strategy development and execution.

December 30, 2019
·
2 min read
Genetown

Abiomed to Present at the 38th Annual J.P. Morgan Healthcare Conference

The conference will be held at the Westin St. Francis Hotel in San Francisco, California.

December 30, 2019
·
2 min read
Pharm Country

Tauriga Sciences, Inc. Commences Development of Cannabigerol “CBG” Isolate Infused Version of Tauri-Gum

The Company expects that the MSRP for its CBG Infused version of Tauri-Gum™ will be set at $19.99 per blister pack.

December 30, 2019
·
4 min read
Business

Fresenius Medical Care North America Continues to Support National Kidney Foundation with Record Fundraising

More Than $1.8 Million Raised During Two Years as National Sponsor of NKF Kidney Walks

December 30, 2019
·
3 min read
Drug Development

Jazz Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 2/3 Study Evaluating JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Pivotal Phase 2/3 study is being conducted in collaboration with Children’s Oncology Group

December 30, 2019
·
9 min read
FDA

Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Molgradexvis an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor, for the treatment of aPAP.

December 30, 2019
·
5 min read